Suchergebnisse - "Biard, Lucie"

PubPharm (4)

1

Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis : A Multicenter Study of 330 Patients

enthalten in: American journal of ophthalmology | 2022

von Maalouf, G. | Andrillon, A. | Leclercq, M. | +18

2

Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema : A Multicenter Study from the French Uveitis Network

enthalten in: Ophthalmology | 2022

von Leclercq, M. | Andrillon, A. | Maalouf, G. | +15

CommentIn: Ophthalmology. 2022 Jul;129(7):e77. - PMID 35346510

3

Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis : multicentre retrospective study of 209 patients

enthalten in: Rheumatology (Oxford, England) | 2022

von Mekinian, A. | Biard, L. | Dagna, L. | +52

4

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis : A Multicenter Study From the French Uveitis Network

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2016

von Vallet, H. | Seve, P. | Biard, L. | +24

1
[1]